Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$0.95 +0.00 (+0.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Creative Medical Technology Holdings' Return on Capital Employed [ROCE] came in at -86.54% for Q2 2026, down 7.07 percentage points from -79.47% a year earlier but up 0.61 percentage points from the prior quarter.

Analysis

Creative Medical Technology Holdings (CELZ) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Creative Medical Technology Holdings' Return on Capital Employed [ROCE] was -88.33%, down 19.66 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a four-year change of -25.08 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -68.67% in FY2024 (-30.12 pp), -38.55% in FY2023 (+47.50 pp), -86.05% in FY2022 (-22.80 pp) and -63.25% in FY2021.
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -97.83% (Q3 2025) to -24.12% (Q3 2022).
  • Year-over-year, Return on Capital Employed [ROCE] has declined for nine consecutive quarters, with an average year-over-year change of -13.42 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q4 2023 (a gain of 8.53 percentage points), and the weakest in Q3 2023 (a drop of 54.39 percentage points).
  • Business Quant data shows CELZ's Return on Capital Employed [ROCE] at -87.15% (Q1 2026), -93.84% (Q4 2025) and -97.83% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Creative Medical Technology Holdings 1.25 Mn 1.27 Mn - -86.54%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -86.54%
Mar 31, 2026 -87.15%
Dec 31, 2025 -93.84%
Sep 30, 2025 -97.83%
Jun 30, 2025 -79.47%
Mar 31, 2025 -86.98%
Dec 31, 2024 -89.04%
Sep 30, 2024 -79.21%
Jun 30, 2024 -71.94%
Mar 31, 2024 -57.59%
Dec 31, 2023 -49.99%
Sep 30, 2023 -78.50%
Jun 30, 2023 -67.25%
Mar 31, 2023 -60.73%
Dec 31, 2022 -58.52%
Sep 30, 2022 -24.12%
Jun 30, 2022 -32.43%
Mar 31, 2022 -39.29%
Dec 31, 2021 -50.83%
Dec 31, 2015 -83.09%
API Access

Creative Medical Technology Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CELZ&period=max&api_key=YOUR_API_KEY